Epithelica is a Berlin-based biotech developing local, non-invasive gene-editing therapies for rare and underserved skin diseases. Built on pioneering research from the Hedtrich Lab, our lipid nanoparticle and RNA-based base-editing platform is designed to correct disease-causing mutations directly in the skin, offering durable, clinic-ready treatments without viral vectors. Our vision is simple: no skin disease is too rare to deserve a precise, scalable, and truly disease-modifying therapy.

Epithelica GmbH

Org chart

Teams

Offices

Epithelica GmbH

Org chart

Teams

Offices

Related companies